Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections.

Sterling RK, Chiu S, Snider K, Nixon D.

Dig Dis Sci. 2008 May;53(5):1375-82. Epub 2007 Oct 16.

2.

Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.

Lobstein S, Kaiser T, Liebert U, Wojan M, Leichtle A, Mössner J, Wiegand J, Tillmann HL.

Z Gastroenterol. 2008 May;46(5):415-20. doi: 10.1055/s-2008-1027157.

PMID:
18461515
3.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

PMID:
23978720
4.

The liver profile in patients with hepatitis C virus and/or fascioliasis.

Wahib AA, el-Nasr MS, Mangoud AM, el-Shazly AM, Morsy AT.

J Egypt Soc Parasitol. 2006 Aug;36(2):405-40.

PMID:
16927859
5.

Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.

Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM.

Cancer. 1998 Sep 15;83(6):1224-30.

PMID:
9740089
6.

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.

Eur J Epidemiol. 1998 Sep;14(6):555-61.

PMID:
9794122
7.

Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.

Audsley J, Seaberg EC, Sasadeusz J, Matthews GV, Avihingsanon A, Ruxrungtham K, Fairley K, Finlayson R, Hwang HS, Littlejohn M, Locarnini S, Dore GJ, Thio CL, Lewin SR.

PLoS One. 2011;6(11):e26482. doi: 10.1371/journal.pone.0026482. Epub 2011 Nov 1.

8.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
9.

Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.

Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, Chiu CC, Huang JF, Chang NC, Wang CL, Dai CY, Chuang WL, Yu ML.

Int J Obes (Lond). 2009 Nov;33(11):1309-17. doi: 10.1038/ijo.2009.172. Epub 2009 Sep 15.

PMID:
19752878
10.

Prevalence and determinants of biochemical dysfunction of the liver in Atayal Aboriginal community of Taiwan: is betel nut chewing a risk factor?

Lin CF, Shiau TJ, Ko YC, Chen PH, Wang JD.

BMC Gastroenterol. 2008 Apr 27;8:13. doi: 10.1186/1471-230X-8-13.

11.

[Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].

Shi JP, Fan JG, Lou GQ, Zhang L, Hu CB, Wu R, Xun YH.

Zhonghua Gan Zang Bing Za Zhi. 2008 Nov;16(11):818-22. Chinese.

PMID:
19032864
12.

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

Kovari H, Ledergerber B, Battegay M, Rauch A, Hirschel B, Foguena AK, Vernazza P, Bernasconi E, Mueller NJ, Weber R.

Clin Infect Dis. 2010 Feb 15;50(4):502-11. doi: 10.1086/649922.

13.

High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.

Gray H, Wreghitt T, Stratton IM, Alexander GJ, Turner RC, O'Rahilly S.

Diabet Med. 1995 Mar;12(3):244-9.

PMID:
7538925
14.

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.

Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E.

BMC Public Health. 2010 Mar 1;10:105. doi: 10.1186/1471-2458-10-105.

15.

Liver enzymes elevation after HAART in HIV-HCV co-infection.

Servin-Abad L, Molina E, Baracco G, Arosemena L, Regev A, Jeffers L, Schiff E.

J Viral Hepat. 2005 Jul;12(4):429-34.

PMID:
15985015
16.

[Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].

Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):585-8. doi: 10.3760/cma.j.issn.1007-3418.2012.08.009. Chinese.

PMID:
23207151
17.

Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.

Navaneethan U, Remzi FH, Nutter B, Fazio VW, Shen B.

Am J Gastroenterol. 2009 Oct;104(10):2467-75. doi: 10.1038/ajg.2009.343. Epub 2009 Jun 23.

PMID:
19550410
18.

Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.

Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95.

PMID:
22864260
19.

Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.

Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M.

J Microbiol Immunol Infect. 2007 Aug;40(4):288-92.

PMID:
17712462
20.

[Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].

Liu M, Yan HM, Gao X, Gao J.

Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):253-5. Chinese.

PMID:
17425870
Items per page

Supplemental Content

Write to the Help Desk